Exjade 250 mg (Deferasirox TABLET FOR SUSPENSION) 250 MG

EXJADE 250 MG tablets for suspension are used to manage iron overload. This medication helps reduce excess iron in the body, often prescribed for conditions like thalassemia.

Strength

250 MG

Pack Size

Manufacturer / TM Owner

NOVARTIS PHARMACEUTICALS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

EXJADE 250 MG is primarily used to treat iron overload, a condition where there is too much iron in the body. This can occur in people who receive frequent blood transfusions, such as those with thalassemia. The medication helps to remove excess iron, which can otherwise cause damage to organs. What is EXJADE used for? It is commonly prescribed for managing iron overload in conditions like beta-thalassemia.

Side Effects

Common effects of EXJADE 250 MG may include gastrointestinal issues like nausea, vomiting, or diarrhea. Some users might experience skin rashes or changes in liver function. It's important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

Precautions & Warnings

EXJADE 250 MG should be used with caution in individuals with liver or kidney problems. Regular monitoring of liver function and blood counts is recommended. The medication should be taken as directed, and any changes in dosage should be discussed with a healthcare provider.

Avoid Interactions

EXJADE 250 MG may interact with certain medications, including those metabolized by the liver. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated, as it may affect the liver's ability to process the medication.

Frequently Asked Questions

EXJADE 250 MG is used to manage iron overload in conditions like thalassemia, helping to reduce excess iron in the body.

EXJADE 250 MG is a tablet for suspension, typically taken orally as directed by a healthcare provider.

Common side effects may include gastrointestinal issues like nausea, vomiting, or diarrhea, as well as skin rashes.

EXJADE 250 MG may interact with certain medications, so it's important to consult a healthcare provider before combining it with other drugs.

Yes, regular monitoring of liver function and blood counts is recommended while taking EXJADE 250 MG.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.